Jennison Associates »

Dianthus Therapeutics shares owned by Jennison Associates

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Jennison Associates from 13F filings

Historical chart of Jennison Associates investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Jennison Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $41M 485k 83.92

More positions owned by Jennison Associates

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Tesla Motors (TSLA)
Ge Aerospace Com New (GE)
Netflix (NFLX)
Mastercard Incorporated Cl A (MA)
Wal-Mart Stores (WMT)

View all positions for Jennison Associates

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Fairmount Funds Management
Wellington Management Company
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics